
In a first-of-its-kind procedure, a team of Japanese researchers announced this week that they had successfully transplanted stem cell-derived cardiac muscle cells into a human patient.
The announcement, from a team based in Osaka University, sought to evaluate the safety and efficacy of using induced pluripotent stem (iPS) cells to grow cardiac tissue, and then implant that tissue into a damaged heart. The research team aimed to transplant the iPS-grown cells into 10 patients over the course of three years. The first transplant was a success, with the patient (who had hypertrophic cardiomyopathy) moving into a general ward for follow-up care.
“I hope that (the transplant) will become a medical technology that will save as many people as possible, as I’ve seen many lives that I couldn’t save,” Yoshiki Sawa, a professor in the Osaka University cardiovascular surgery unit, said in a press report.